Fundz

Epigenic raises $60m for epigenetic treatment development.

PRIVATESep 09, 2025

Amount Raised

$60 Million

Round Type

Funding Round

ShanghaiBiotechnologyHealth Careresearch

Description

Epigenic has successfully raised $60 million to advance the development of their epigenetic treatments. This round of funding will facilitate further research and enhancement of their innovative therapeutic solutions. The investment highlights the growing interest in epigenetics as a promising field. This funding will accelerate their product development timeline.

Quick answer

Epigenic Therapeutics raised $60 Million in a Funding Round round, dated September 9, 2025. Epigenic Therapeutics is based in Shanghai, Shanghai, China.

How much did Epigenic Therapeutics raise?
Epigenic Therapeutics raised $60 Million in a Funding Round round on September 9, 2025.
What does Epigenic Therapeutics do?
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
Where is Epigenic Therapeutics based and how big is it?
Epigenic Therapeutics is based in Shanghai, Shanghai, China. Fundz records about 13 employees.
Who are the decision-makers at Epigenic Therapeutics?
Fundz holds 2 contacts at Epigenic Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Epigenic Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
  • Bexorg raised $23M (Series A) on October 16, 2025.
  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Kardigan raised $254M (Series B) on October 14, 2025.

Who to call at Epigenic Therapeutics, and when

A new round usually means Epigenic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Epigenic Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Epigenic Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epigenic Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epigenic Therapeutics

Location

Shanghai, Shanghai, China

About

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple product candidates in the pipeline, including treatment for metabolic, cardiovascular, viral hepatitis, ocular and rare diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epigenic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Epigenic Therapeutics's next move

See what Strategic adds

Epigenic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.